Leaderboards/Antibiotics Pharmacokinetics and Efficacy

Antibiotics Pharmacokinetics and Efficacy

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Samuel Ajulo
Texas Tech University
2
Kevin S. Blake
Washington University in St. Louis
3
Wondimeneh Dubale Adane
Addis Ababa University
4
Heloisa Ehalt Macedo
McGill University
5
Cornelis J. Slingerland
Leiden University
6
Su-fang Kuang
Jiangxi Normal University
7
Gabriel Mendes
University of Lisbon
8
Brenda A Warecki
Consejo Nacional de Investigaciones Científicas y Técnicas
9
Biyang Tu
Nanjing University of Posts and Telecommunications
10
Lilly Josephine Bindel
Medizinische Hochschule Hannover

Papers

1
Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries
PLoS ONE|2024
226 cit.
2
Recent Advances in the Development of Polymyxin Antibiotics: 2010–2023
ACS Infectious Diseases|2024
56 cit.
3
Antibiotics in the global river system arising from human consumption
PNAS Nexus|2025
50 cit.
4
A cutting-edge electrochemical sensing platform for the simultaneous determination of the residues of antimicrobial drugs, rifampicin and norfloxacin, in water samples
Analytica Chimica Acta|2024
37 cit.
5
Hypersensitive electrochemical sensor based on thermally annealed gold–silver alloy nanoporous matrices for the simultaneous determination of sulfathiazole and sulfamethoxazole residues in food samples
Food Chemistry|2024
33 cit.
6
A novel electrochemical sensor for the detection of metronidazole residues in food samples
Chemosphere|2024
32 cit.
7
Publication in Nature Microbiology (2025) [26 citations, W4413106826]
Nature Microbiology|2025
26 cit.
8
A novel electrochemical sensor (Au-Ag-ANCCs/r-GO/poly(L-histidine)/GCE) for the simultaneous determination of vancomycin and ceftriaxone residues in chicken meat, fish, and milk samples
Chemical Engineering Journal|2024
19 cit.
9
A pioneering electrochemical sensor for the simultaneous determination of nitrofurantoin and furazolidone residues in food and municipal wastewater samples
Sensing and Bio-Sensing Research|2024
15 cit.
10
Multi-elemental nanocomposite electrochemical sensor for the simultaneous determination of azithromycin and enrofloxacin residues in food and water samples
Microchemical Journal|2025
14 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Benjamin M. Lomaestro
Albany Medical Center Hospital
2
Yao Wang
Incyte (United States)
3
N Mariano
Garrahan Hospital
4
Vigneshwaran Easwaran
King Khalid University
5
Indy Sandaradura
Westmead Hospital
6
Donato Teutonico
Sanofi (France)
7
Patricia J. Simner
Mayo Clinic
8
Emi Minejima
University of Southern California
9
Radojka M. Savić
University of California, San Francisco
10
Elodie Moreau-Guigon
Continental (United States)

Papers

1
Evaluation of Metagenomic and Targeted Next-Generation Sequencing Workflows for Detection of Respiratory Pathogens from Bronchoalveolar Lavage Fluid Specimens
Journal of Clinical Microbiology|2022
198 cit.
2
Status check: next-generation sequencing for infectious-disease diagnostics
Journal of Clinical Investigation|2024
70 cit.
3
An NDM-Producing <i>Escherichia coli</i> Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance
Open Forum Infectious Diseases|2023
66 cit.
4
Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution Test
Journal of Clinical Microbiology|2023
45 cit.
5
Combination of phage therapy and cefiderocol to successfully treat <i>Pseudomonas aeruginosa</i> cranial osteomyelitis
JAC-Antimicrobial Resistance|2022
39 cit.
6
Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing
Antimicrobial Agents and Chemotherapy|2022
38 cit.
7
Raising the Bar: Improving Antimicrobial Resistance Detection by Clinical Laboratories by Ensuring Use of Current Breakpoints
Open Forum Infectious Diseases|2022
32 cit.
8
Comparing the activity of novel antibiotic agents against carbapenem-resistant Enterobacterales clinical isolates
Infection Control and Hospital Epidemiology|2022
27 cit.
9
Examining nonadherence in the treatment of tuberculosis: The patterns that lead to failure
British Journal of Clinical Pharmacology|2022
25 cit.
10
Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures
Clinical Infectious Diseases|2022
25 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
‪Damià Barceló
University of Almería
2
David P. Nicolau
Hartford Hospital
3
Otto Cars
Uppsala University
4
David C. Hooper
Massachusetts General Hospital
5
Jason A. Roberts
Université de Montpellier
6
Michael J. Rybak
Eugene Applebaum College of Pharmacy and Health Sciences
7
George L. Drusano
University of Florida
8
Patrice Nordmann
University of Fribourg
9
Robert A. Bonomo
Louis Stokes Cleveland VA Medical Center
10
Jerome J. Schentag
University of Saskatchewan

Papers

1
Antibiotic resistance—the need for global solutions
The Lancet Infectious Diseases|2013
4.4k cit.
2
Multiplex PCR for detection of acquired carbapenemase genes
Diagnostic Microbiology and Infectious Disease|2011
2k cit.
3
Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments
Talanta|2005
1.7k cit.
4
Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment
Water Research|2008
1.2k cit.
5
Therapeutic monitoring of vancomycin for serious methicillin-resistant <i>Staphylococcus aureus</i> infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
American Journal of Health-System Pharmacy|2020
1.1k cit.
6
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Antimicrobial Agents and Chemotherapy|1993
1.1k cit.
7
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Clinical Infectious Diseases|2014
1.1k cit.
8
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Nature Medicine|2005
1k cit.
9
Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment
Water Research|2010
978 cit.
10
Emergence of Oxacillinase-Mediated Resistance to Imipenem in<i>Klebsiella pneumoniae</i>
Antimicrobial Agents and Chemotherapy|2003
972 cit.

Reagents for Antibiotics Pharmacokinetics and Efficacy

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 64

PathScan® Total Axl Sandwich ELISA Kit

#7040$66,129,740
View Evidence →
Cell Signaling TechnologyEvidence 61

AsCpf1/Cas12a (Strain BV3L6) (E1U7C) Rabbit Monoclonal Antibody

#19984$175,354
View Evidence →
Cell Signaling TechnologyEvidence 65

VCAM-1 Antibody

#14694$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

LIMP-2/SCARB2 (E2Z5F) Rabbit Monoclonal Antibody

Cited in 33 papers
#27960$160,351
View Evidence →
Cell Signaling TechnologyEvidence 67

DUSP6/MKP3 Antibody

#50945$317
View Evidence →
Bio-RadEvidence 74

Trans-Blot Turbo Nitrocellulose Transfer Packs, Mini

#1704158
View Evidence →